Anything less is not only risky for patients but also for the clinicians licenses and livelihoods
Okay, so, technically, there is no such thing as a GLP-3 drug
Having an alternative treatment option could increase accessibility and acceptance given the lower adoption rate of existing FDA approved AUD medications
The most common microdose protocols use 0.0625 mg, 0.1 mg, 0.125 mg, or 0.15 mg per week
But heres the part most people dont know: Any shift outside that range can signal breakdown, contamination, or improper storage
It is believed to continue targeting appetite receptors in the brain, which may potentially enhance the feeling of fullness and further reduce caloric intake as your body adjusts